Al-Hamodi, Z. (2012). Plasminogen activator inhibitor-1 4G/5G polymorphism is associated with metabolic syndrome parameters in Malaysian subjects.
Chicago Style CitationAl-Hamodi, Z.H. Plasminogen Activator Inhibitor-1 4G/5G Polymorphism Is Associated With Metabolic Syndrome Parameters in Malaysian Subjects. 2012.
MLA CitationAl-Hamodi, Z.H. Plasminogen Activator Inhibitor-1 4G/5G Polymorphism Is Associated With Metabolic Syndrome Parameters in Malaysian Subjects. 2012.
Warning: These citations may not always be 100% accurate.